2016
DOI: 10.1016/j.jpba.2015.10.042
|View full text |Cite
|
Sign up to set email alerts
|

α-Glucosidase and α-amylase inhibitors from Myrcia spp.: a stronger alternative to acarbose?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

5
27
0
2

Year Published

2016
2016
2024
2024

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 71 publications
(34 citation statements)
references
References 18 publications
5
27
0
2
Order By: Relevance
“…Most of the studied plant samples were potent inhibitors of α-glucosidase, showing higher acarbose equivalent values, compared to α-amylase inhibition. Indeed, mild α-amylase inhibition versus marked α-glucosidase inhibition was requested, since a pronounced activity of the former enzyme advocated the event of gastrointestinal problems [ 30 ]. Specifically, the roots of flowering AL collected in Novele showed high α-glucosidase inhibitory activity and low inhibition against α-amylase.…”
Section: Discussionmentioning
confidence: 99%
“…Most of the studied plant samples were potent inhibitors of α-glucosidase, showing higher acarbose equivalent values, compared to α-amylase inhibition. Indeed, mild α-amylase inhibition versus marked α-glucosidase inhibition was requested, since a pronounced activity of the former enzyme advocated the event of gastrointestinal problems [ 30 ]. Specifically, the roots of flowering AL collected in Novele showed high α-glucosidase inhibitory activity and low inhibition against α-amylase.…”
Section: Discussionmentioning
confidence: 99%
“…Trilobatin also exhibits anti-hyperglycemic properties by accelerating liver glycogen synthesis, decreasing oxidative stress, increasing the expression of glucokinase, and up-regulating the expression of insulin receptor substrate (IRS) on long-term double high-fat diet and streptozotocin (STZ) induced type 2 diabetic mice [13]. Similar to other dihydrochalcones, phlorizin (a dual SGLT1/SGLT2 inhibitor) [14], phloretin (a GLUT2 inhibitor) [15], and acarbose (an alpha-glucosidase inhibitor) [16,17], our previous works demonstrated that trilobatin could be bind with SGLT1/2 [18]. But up to now, the effect of trilobatin on insulin resistance is still needed to be identified.…”
Section: Introductionmentioning
confidence: 99%
“…[17] Therefore, a compound with dual inhibition may elicit its pharmacological effects while minimizing its side effects. [18] The results presented here indicate that compound 1 is a promising α-amylase and α-glucosidase inhibitor for Figure S1). Figure 3.…”
Section: Discussionmentioning
confidence: 69%